OMNIlife Science Inc. will be the exclusive U.S. distributor of articulation technology used in artificial hips made by a French maker of orthopedic and dental implants.

Taunton, Mass.-based OMNIlife said the deal with Societe d’Etudes Recherches Fabrication-Dedienne Sante will begin as soon as the company receives regulatory approval from the Food & Drug Administration. Further terms of the deal were not announced.

OMNIlife, which was founded in 1999, is owned by holding company Orthopaedic Synergy Inc., which is also based in Taunton. The company designs, manufactures and distributes a suite of hip and knee reconstruction products.

It’s the second foray into France this week for Orthopaedic Synergy, which March 9 announced an agreement to acquire Praxim SA, which makes robotic and computer-assisted surgery devices.